Nordøy A, Marchioli R, Arnesen H, Videbaek J
Department of Medicine, University of Tromsø, Norway.
Lipids. 2001;36 Suppl:S127-9. doi: 10.1007/s11745-001-0695-7.
An expert round table discussion on the relationship between intake of n-3 polyunsaturated fatty acids (PUFA) mainly of marine sources and coronary heart disease at the 34th Annual Scientific Meeting of European Society for Clinical Investigation came to the following conclusions: 1. Consumption of 1-2 fish meals/wk is associated with reduced coronary heart disease (CHD) mortality. 2. Patients who have experienced myocardial infarction have decreased risk of total, cardiovascular, coronary, and sudden death by drug treatment with 1 g/d of ethylesters of n-3 PUFA, mainly as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The effect is present irrespective of high or low traditional fish intake or simultaneous intake of other drugs for secondary CHD prevention. n-3 PUFA may also be given as fatty fish or triglyceride concentrates. 3. Patients who have experienced coronary artery bypass surgery with venous grafts may reduce graft occlusion rates by administration of 4 g/d of n-3 PUFA. 4. Patients with moderate hypertension may reduce blood pressure by administration of 4 g/d of n-3 PUFA. 5. After heart transplantation, 4 g/d of n-3 PUFA may protect against development of hypertension. 6. Patients with dyslipidemia and or postprandial hyperlipemia may reduce their coronary risk profile by administration of 1-4 g/d of marine n-3 PUFA. The combination with statins seems to be a potent alternative in these patients. 7. There is growing evidence that daily intake of up to 1 energy% of nutrients from plant n-3 PUFA (alpha-linolenic acid) may decrease the risk for myocardial infarction and death in patients with CHD. This paper summarizes the conclusions of an expert panel on the relationship between n-3 PUFA and CHD. The objectives for the experts were to formulate scientifically sound conclusions on the effects of fish in the diet and the administration of marine n-3 PUFA, mainly eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), and eventually of plant n-3 PUFA, alpha-linolenic acid (ALA, 18:3n-3), on primary and secondary prevention of CHD. Fish in the diet should be considered as part of a healthy diet low in saturated fats for everybody, whereas additional administration of n-3 PUFA concentrates could be given to specific groups of patients. This workshop was organized on the basis of questions sent to the participants beforehand, on brief introductions by the participants, and finally on discussion and analysis by a group of approximately 40 international scientists in the fields of nutrition, cardiology, epidemiology, lipidology, and thrombosis.
在欧洲临床研究学会第34届年度科学会议上,就主要来源于海洋的n-3多不饱和脂肪酸(PUFA)摄入量与冠心病之间的关系举行了一场专家圆桌讨论,得出了以下结论:1. 每周食用1 - 2次鱼餐与降低冠心病(CHD)死亡率相关。2. 心肌梗死患者通过每日服用1克n-3 PUFA乙酯(主要为二十碳五烯酸(EPA)和二十二碳六烯酸(DHA))进行药物治疗,可降低全因死亡、心血管死亡、冠心病死亡及猝死风险。无论传统鱼类摄入量高低,或同时服用其他用于冠心病二级预防的药物,该效果均存在。n-3 PUFA也可通过食用富含脂肪的鱼类或甘油三酯浓缩物来补充。3. 接受静脉移植冠状动脉搭桥手术的患者,每日服用4克n-3 PUFA可降低移植血管闭塞率。4. 中度高血压患者每日服用4克n-3 PUFA可降低血压。5. 心脏移植后,每日服用4克n-3 PUFA可预防高血压的发生。6. 血脂异常和/或餐后高脂血症患者每日服用1 - 4克海洋n-3 PUFA可降低其冠心病风险谱。与他汀类药物联合使用似乎是这些患者的有效替代方案。7. 越来越多的证据表明,每日从植物n-3 PUFA(α-亚麻酸)中摄入高达1%能量的营养素,可能降低冠心病患者心肌梗死和死亡风险。本文总结了一个专家小组关于n-3 PUFA与CHD关系的结论。专家们的目标是就饮食中的鱼类以及海洋n-3 PUFA(主要为二十碳五烯酸(EPA,20:5n-3)和二十二碳六烯酸(DHA,22:6n-3)),最终还有植物n-3 PUFAα-亚麻酸(ALA,18:3n-3)对冠心病一级和二级预防的作用,得出科学合理的结论。饮食中的鱼类应被视为每个人低饱和脂肪健康饮食的一部分,而n-3 PUFA浓缩物可额外给予特定患者群体。本次研讨会是根据事先发给参与者的问题、参与者的简要介绍,最后由营养、心脏病学、流行病学、脂质学和血栓形成领域的约40名国际科学家进行讨论和分析而组织的。